Browse By: Country ι Category ι Publisher ι Tag

Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues, 2013 Edition

Pages » 208
Published By » JustPharmaReports.com
Price » $2350
In stock
View Report Details
Description

The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing clinical need, a strong patient voice and the treatments themselves sometimes offer the only hope. But is this enough to assure premium prices and special status in an era of budget limitations, and growing demands for evidence of clinical and cost effectiveness? Payers are becoming increasingly strict. Four of the first seven orphan drugs to enter Germany’s AMNOG procedure were considered to bring only minor additional benefit and for two others the benefit was deemed non-quantifiable.... Click here for more details


Orphan Drugs in Europe: Pricing, Reimbursement, Funding & Market Access Issues, 2011 Edition
The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing clinical need, a strong patient voice and the treatments themselves sometimes offer the only h
Published Date: Jun 2011
Price: $2300
Market Access Korea: Breaking into the Developed World\'s Fastest Growing Pharmaceutical Market
South Korea as a country has been an economic success story and the origin of much cutting edge technology, but its pharmaceutical market can now also be given ‘Asian tiger’ status. The past four years have seen total sales growth of 15.6%, 13.5%, 12.4% and 13.8% respectively. IMS
Published Date: Nov 2010
Price: $1380
Orphan Drugs in Asia-Pacific: From Designation to Pricing, Funding & Market Access
A major new report Orphan Drugs in Asia-Pacific: From designation to pricing, funding and market access focuses on five developed markets in the region: Japan, South Korea, Taiwan, Singapore and Australia. Each has passed specific measures to promote the development, registration and/or commer
Published Date: Feb 2010
Price: $2320
Biosimilars: Current Situation & Future Prospects, Worldwide
The engine of the biosimilar sector is the same as with small molecule drugs, patent expiry. On this basis, prospects for biosimilars look good, with the vast majority of leading originator brands in the global biologics market expected to lose some degree of protection by 2019. All major countr
Published Date: Mar 2012
Price: $3000
Pharmaceutical Pricing & Distribution in Japan, 2010 Update
The author’s 2008 major title ‘Pharmaceutical Pricing & Distribution in Japan’ was described by PhRMA Japan as ‘a superb report…to understand Japan there is nothing better’. His new report packs all the essentials needed to optimise market access and life
Published Date: Oct 2011
Price: $760
Pharmaceutical Pricing & Distribution in Japan, 2012 Update
No serious pharmaceutical company can afford to ignore Japan, a $120 billion market, the second-largest in the world. It remains a tough and highly competitive market to crack, however, with the environment for developing and marketing medicines dominated by price.  No new bran
Published Date: Jun 2012
Price: $1400
Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwide
Managed entry agreements apply to an increasing number of new, innovative drugs in a growing number of markets. They are designed to share the risk between the manufacturer and the payer, consequent on uncertainties - usually at launch - about the product’s value (clinical- and cost-effect
Published Date: Feb 2013
Price: $1050
Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues, 2013 Edition
The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing clinical need, a strong patient voice and the treatments themselves sometimes offer the only hope. B
Published Date: Oct 2013
Price: $2350

 


 

Related News

Brent Crude Oil Prices Rise Above $97 after China: reports PMI
Brent crude experienced a rise of $97 per barrel on Tuesday. This was after a factory in China unexpectedly soared in terms of demand outlook in the global market in September.  The expectations proposed by the analysts for a reading of 50 about Brunt crude oil were beat from 50.2 in August to 50.5 in September as orders continued to rise, reported the HSBC China Purchasing Managers’ Index (PMI).  For November, Brent was up 15 cents by 0646 GMT reaching a value $97.12 per b
Date: Sep 25

Apples Large Screen iPhone 6 Plus Finally Launched in the Chinese Market
The large screen iPhone 6 Plus of Apple Inc. has finally been launched in the world’s largest market for smart phones. With this, the consumers in the Chinese market will not have to depend on smugglers. This product has recently been introduced in the Chinese market for sale. The starting price of this 4.7 inch iPhone 6 is about US$ 863 (5288 Yuan).  Earlier, due to high demand for the 5.5 inch iPhone 6 Plus in the Chinese market, these phones were being bought illegally across th
Date: Oct 20

Bay Link Manufacturing to Reinvent Manufacturing Sector in Wisconsin
The Green Bay School plans to revolutionize the manufacturing sector through its collaborative, Bay Link Manufacturing. With this initiative, students at Green Bay Area School District will have chance to get a hands-on experience in manufacturing and business sectors. The Bay Link Manufacturing at West High School is a program launched in association with NWTC and the Green Bay Area Schools, with planning that has spanned over two years. The Bay Link will allow students to learn actual skill
Date: Oct 16

Pepsico to Fund “Spoon” with USD 5 Million
In an initiative launched by Inter-American development Bank on Wednesday areas such as Peru, Mexico, Guatemala, and Colombia will receive aid and assistance in reducing the risks of both, obesity and malnutrition for the children aged fewer than five. These areas are considered to be some of the disadvantaged areas. The IDB President, Luis Alberto Monreno affirmed this point saying, the program “Spoon” has been designed to prevent undernutrition and reduce the chances of children su
Date: Oct 16

A New Nano Device for Blood Analysis
A new sensor has been developed by a team of researchers at the Center for Scientific Research and Higher Education of Ensenada, Baja California (CICESE). This research has been conducted in the area of Nano-Optics. This sensor is based on the properties of light to carry out blood analysis thereby, enabling the health specialists and physicians to get accurate and exact information. The development of this sensor has been allowed to obtain a patent and its publication has been permitted in seve
Date: Oct 16

Lenovo Plans New Mobile Phone Company in China
Smartphone and Personal Computer maker Lenovo Group Ltd. announced it would form a new Chinese company in the coming year. The new company would focus on selling mobile phones online. The new company is a part of Lenovo’s strategy to fight off the fierce competition offered by the Chinese Xiaomi Inc., a startup company that sells all its handsets online and generates a fan following through self-made software, entertainment offerings and services. Lenovo stated on Wednesday that it w
Date: Oct 16

Roche Observes Sales Rise of New Drugs in Third Quarter
Roche Holding AG, the French drug manufacturer, observed a 1.8% rise in revenue in its third quarter due to high sales of its new cancer drugs Perjeta and Kadcyla. With this rise, company’s shares climbed to $12.5 billion (11.8 billion Swiss francs) from the 11.6 billion francs in the last year, a report from the Basel, a Switzerland based analyst firm mentioned in a statement. This has beaten the average of analysis developed by some analysts, of 11.6 billion franc. Revenues from th
Date: Oct 16

How Effective is Learning Modern Foreign Languages in Primary School?
While may agree that introducing foreign languages in the school curriculum at the primary level is a good move towards language education, there are still a group of people who question how much will this decision affect the overall, long-term scenario.  A revised curriculum in England’s primary schools states that all schools using the national curriculum will have to teach pupils a modern foreign language at the primary key stage 2. As a result of this, students from the age of
Date: Oct 15

Citigroup to Shun its Consumer Banking Business in 11 Countries
Citigroup Inc., the U.S. bank that earns most of its revenues from lending money in overseas markets, has announced that it is planning to exit the business of consumer banking from 11 markets. The decision is believed to be a part of company CFO Michel Corbat’s efforts in simplifying the firm and boosting its returns. The sale of the consumer banking businesses, a major part of which is already under way, could be completed by the end of the next year, the bank stated in an official st
Date: Oct 15

Contractors Aware of Concrete Pump Shortage
The concrete industry was functioning well until the abrupt stop in Professional Concrete Pumping occurred yesterday. Due to the collapse of industry’s biggest player this week, construction contractors are expected to witness a major delay in their order for concrete pumps.  Camfaud – the biggest supplier and industry rival has warned about the industry-wide shortage of industrial machines and how the need would arise to manage extra demand from existing Professional custome
Date: Oct 15

Upcoming Reports

Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency Market Research
Price: $4795
Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti
Published By: Transparency Market Research
Price: $4795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency Market Research
Price: $4795
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency Market Research
Price: $4795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency Market Research
Price: $4795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency Market Research
Price: $4795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency Market Research
Price: $4795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency Market Research
Price: $4795
EPharmacies Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
The global market for ePharmacies is projected to reach USD 51.75 billion by the end of 2017 owing to the increasing number of tech-savvy people and rising demand for prescription drugs. The ePharmacies meeting the regulatory standards set by the government and following ethical business practices
Published By: Transparency Market Research
Price: $4795
Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American mar
Published By: Transparency Market Research
Price: $4795